Skip to content

Health Care

No AI chatbot is FDA-authorized for mental health support, GAO finds

By Central TribunePublished

Corner of the large limestone Government Accountability Office building in Washington on a clear day, with trees and a crosswalk
Photo: ajay_suresh / Wikimedia Commons (CC BY 2.0)

Nearly one-fifth of Americans aged 12 to 21 turned to AI chatbots for advice on their mental health in 2025, yet the Food and Drug Administration has not authorized any chatbot to support mental health, the Government Accountability Office said.

For parents of teens and young adults, that means none of the programs young people turn to for that kind of help carries FDA authorization for it.

General-purpose chatbots answer questions on almost any topic a user raises.

"Experts warn that general-purpose chatbots are not designed for such needs and can be dangerous if used for this purpose," the GAO said in its report, Science & Tech Spotlight: AI Chatbots and Mental Health.

Even chatbots built for mental health use are "not a replacement for qualified mental health providers," the office said, though they may be designed to help.

Part of the risk lies in how the programs talk. Chatbots tend to agree with and flatter their users and reinforce their point of view, a habit the GAO calls sycophantic.

"Settings for how agreeably chatbots interact with users are critical, and some guardrails may not be effective," the report said.

Rules for the programs are still taking shape. Along with the potential for harm and effectiveness that has not been proven, the GAO counts evolving regulations among the challenges.

In this article:GAOFDAartificial intelligencechatbotsmental healthyouth